1. Home
  2. KVHI vs CABA Comparison

KVHI vs CABA Comparison

Compare KVHI & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVHI
  • CABA
  • Stock Information
  • Founded
  • KVHI 1978
  • CABA 2017
  • Country
  • KVHI United States
  • CABA United States
  • Employees
  • KVHI N/A
  • CABA N/A
  • Industry
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KVHI Technology
  • CABA Health Care
  • Exchange
  • KVHI Nasdaq
  • CABA Nasdaq
  • Market Cap
  • KVHI 101.7M
  • CABA 118.8M
  • IPO Year
  • KVHI 1996
  • CABA 2019
  • Fundamental
  • Price
  • KVHI $5.30
  • CABA $1.91
  • Analyst Decision
  • KVHI
  • CABA Strong Buy
  • Analyst Count
  • KVHI 0
  • CABA 9
  • Target Price
  • KVHI N/A
  • CABA $20.33
  • AVG Volume (30 Days)
  • KVHI 33.1K
  • CABA 2.3M
  • Earning Date
  • KVHI 05-07-2025
  • CABA 05-15-2025
  • Dividend Yield
  • KVHI N/A
  • CABA N/A
  • EPS Growth
  • KVHI N/A
  • CABA N/A
  • EPS
  • KVHI N/A
  • CABA N/A
  • Revenue
  • KVHI $109,975,000.00
  • CABA N/A
  • Revenue This Year
  • KVHI $4.22
  • CABA N/A
  • Revenue Next Year
  • KVHI $13.27
  • CABA N/A
  • P/E Ratio
  • KVHI N/A
  • CABA N/A
  • Revenue Growth
  • KVHI N/A
  • CABA N/A
  • 52 Week Low
  • KVHI $4.17
  • CABA $0.99
  • 52 Week High
  • KVHI $6.16
  • CABA $13.50
  • Technical
  • Relative Strength Index (RSI)
  • KVHI 62.40
  • CABA 63.79
  • Support Level
  • KVHI $5.36
  • CABA $1.68
  • Resistance Level
  • KVHI $5.60
  • CABA $1.99
  • Average True Range (ATR)
  • KVHI 0.18
  • CABA 0.19
  • MACD
  • KVHI 0.03
  • CABA 0.02
  • Stochastic Oscillator
  • KVHI 67.69
  • CABA 69.44

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: